How much funding has Minos Biosciences raised?

Minos Biosciences has raised $1.8M in total funding, most recently a Seed round.

Who are Minos Biosciences's investors?

Minos Biosciences's investors include Elaia.

When was Minos Biosciences founded?

Minos Biosciences was founded in 2020.

Where is Minos Biosciences headquartered?

Minos Biosciences is headquartered in Paris, France.

What industry is Minos Biosciences in?

Minos Biosciences operates in Biotech, Healthcare.

How many employees does Minos Biosciences have?

Minos Biosciences has 1-10 employees.

Minos Biosciences

Paris, France · Founded 2020 · $1.8M raised

Biotech

Healthcare

Headquarters: Paris
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: minosbiosciences.com
Total Funding: $1.8M
Last Round: $1.8M SeedApr 2021
Rounds: 1

About

Minos Biosciences is a Paris-based deeptech startup spun out of ESPCI Paris-PSL, developing a breakthrough platform for high-throughput single-cell analysis. The company's technology combines state-of-the-art microfluidics, molecular biology, image analysis, and bioinformatics to directly couple phenotypic data (microscopy) with multi-omic data (DNA/RNA sequencing) at single-cell resolution across tens of thousands of cells simultaneously. Founded in January 2020 by researchers Hubert Geisler and Gael Blivet-Bailly, Minos targets the life sciences research and clinical diagnostics markets, with applications in oncology and personalized medicine. The company raised a 1.5M EUR seed round in 2021 led by Elaia through the PSL Innovation Fund.

Summary

Minos Biosciences is a Biotech company based in Paris, France, founded in 2020. It has raised $1.8M in total across 1 round, most recently a $1.8M Seed round in Apr 2021. Investors include Elaia.